Cytarabine
20 mg/mL · Injection, Solution
- Prescription only
- Nucleoside Metabolic Inhibitor
- Active substance
- Cytarabine
- Made by
- Sagent Pharmaceuticals
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
BulgariaNo exact match for this strength and form
European UnionNo exact match for this strength and form
France2 matching products
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Sagent Pharmaceuticals |
|---|---|
| Active substance | Cytarabine |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 20 mg/mL |
| Form | Injection, Solution |
| Route | Intrathecal; Intravenous; Subcutaneous |
| Packs | 5 VIAL in 1 CARTON / 5 mL in 1 VIAL |
| NDC | 25021-229 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
9 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection, Solution9 products
- 2 g/20mL
20 mg/mL4
20 mg/mL · 4 companies
- Gland Pharma Limited
- Hospira, Inc.
- Meitheal Pharmaceuticals Inc.
- Sagent Pharmaceuticals · this page
100 mg/mL4
100 mg/mL · 4 companies
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.